

Free BAC Waterwith every orderCJC-1295 without DAC + IPA
₡53,487. The bigger discount applies; not combined with volume pricing.
Frequently ordered together
₡53,487
Specifications
Questions
The compound and amount on the label, as lyophilized powder (or ready-to-use liquid for blends and waters). Most products have a Certificate of Analysis confirming identity and purity.
2–4 business days anywhere in Costa Rica, tracked, from our own cold storage. No customs or import fees.
Card, SINPE Móvil or bank transfer.
15% off 5+ vials of the same product, 20% off 10+. The best discount applies automatically. Every order includes a free BAC Water 3 ml, and delivery is free over ₡89,145.
No. All products are for laboratory research use only. We don't provide dosing or medical advice.
Why order from us
What people say
★★★★★Excellent service, quality, and price. For me, they are the best in Costa Rica; I hope they never change.
★★★★★Hay stock y son rápidos y asesoran muy bien, confiable los pagos y el producto llega en buen estado.
★★★★★Son excelentes, mil estrellas.
More in GH secretagogues
Research use only. Supplied for laboratory research. Not for human or veterinary use. We do not provide dosing or medical advice.
Info
What Is in This Vial Component One: CJC-1295 without DAC Also called Modified GRF (1-29). A 29-residue analogue of growth hormone releasing hormone, built on the GHRH 1-29 backbone with four amino acid substitutions chosen to resist enzymatic cleavage. Molecular formula C152H252N44O42, molecular weight 3367.90, CAS 863288-34-0. It carries no albumin-binding group, which is what distinguishes it from the with-DAC form and accounts for its much shorter reported half-life. Component Two: Ipamorelin A pentapeptide, Aib-His-D-2-Nal-D-Phe-Lys-NH2, molecular formula C38H49N9O5, molecular weight 711.87, CAS 170851-70-4. Developed by Novo Nordisk under the code NNC 26-0161. It is a selective agonist at the ghrelin receptor, GHS-R1a. The published selectivity data is the notable part: unlike earlier secretagogues in its class it does not raise prolactin, FSH, LH, TSH, ACTH or cortisol in the reported studies. Two Receptors, Not One The two compounds reach the same endpoint by different routes. CJC-1295 binds the growth hormone releasing hormone receptor on anterior pituitary somatotrophs, raising intracellular cyclic AMP. Ipamorelin binds GHS-R1a, the ghrelin receptor, which signals through a different intracellular pathway. Combined stimulation of both receptor systems is a recognised subject in endocrine research, which is the reason the two are supplied together. Clinical Development of Both Neither compound is approved anywhere. CJC-1295 reached phase 2 under ConjuChem Biotechnologies in lipodystrophy and growth hormone deficiency; development stopped after the death of a trial participant, attributed by the attending physician to pre-existing coronary artery disease and judged unrelated, but the programme ended as a precaution. Ipamorelin reached phase 2 with Helsinn Therapeutics for postoperative ileus and was discontinued for lack of efficacy
CJC-1295 without DAC + IPA Price in Costa Rica
CJC-1295 without DAC + Ipamorelin is listed in a single 10mg combined-mass vial at Peptides Costa Rica. Pricing in Costa Rican colones:
Why Researchers Choose CJC‑1295 Without DAC + IPA
Two defined peptides in one vial, each with published specifications and per-component quantities on the batch certificate.
Trusted Source for Research Peptides
Trusted Source for Research PeptidesWe provide high-quality research compounds with a focus on purity, consistency, and transparency. All products are carefully sourced, reliably handled, and supported with fast delivery across Costa Rica.
How to order
- 1ChoosePick the strength and quantity. Bulk discounts apply automatically.
- 2CheckoutPay by card, or send the order on WhatsApp for SINPE or bank transfer.
- 3ReceiveDelivered in 2–4 days with your batch COA.
CJC-1295 + Ipamorelin FAQ
Ipamorelin. It is a five-residue peptide, CAS 170851-70-4, and it is the second active component in the vial. IPA on this listing does not mean isopropyl alcohol, and no alcohol is present in the product. Both components are peptides supplied as lyophilised powder.
Two synthetic peptides at a stated combined mass of 10mg. CJC-1295 without DAC, a 29-residue GHRH analogue also called Modified GRF (1-29), CAS 863288-34-0. And Ipamorelin, a pentapeptide, CAS 170851-70-4. The quantity of each is stated on the batch Certificate of Analysis rather than inferred from the combined total.
The with-DAC form carries a maleimidopropionyl group on a thirtieth residue that bonds covalently to serum albumin, extending its reported half-life to roughly six to eight days. The without-DAC form has no such group; its reported half-life is around thirty minutes. They are different molecules with different CAS numbers and different molecular weights. See the CJC-1295 with DAC page.
Different ones. CJC-1295 without DAC binds the growth hormone releasing hormone receptor on anterior pituitary somatotrophs. Ipamorelin binds GHS-R1a, the ghrelin receptor. Both pathways converge on growth hormone release but through separate receptors and separate intracellular signalling.
The published data. Earlier compounds in the growth hormone secretagogue class also raised prolactin, ACTH and cortisol. Ipamorelin, developed by Novo Nordisk under the code NNC 26-0161, is reported not to affect prolactin, FSH, LH, TSH, ACTH or cortisol. That selectivity is the reason it remained of research interest after its clinical programme ended.
Both reached phase 2. CJC-1295 was trialled by ConjuChem Biotechnologies in lipodystrophy and growth hormone deficiency; the programme was discontinued after a participant died, a death attributed by the attending physician to pre-existing coronary artery disease and judged unrelated to treatment. Ipamorelin was trialled by Helsinn Therapeutics for postoperative ileus and discontinued for lack of efficacy. Neither holds approval anywhere.
Yes, both, at all times. They fall under Section S2 of the World Anti-Doping Agency Prohibited List, covering growth hormone, its fragments and its releasing factors — CJC-1295 as a GHRH analogue, Ipamorelin as a growth hormone secretagogue. Prohibited in and out of competition, with established detection methods.
Store the sealed vial refrigerated at 2–8°C, or frozen for long-term storage. Both peptides are markedly less stable in solution than as lyophilised powder, and a reconstituted mixture should be kept refrigerated and protected from light. Avoid repeated freeze-thaw cycles. Keep vials sealed until use. Material is non-sterile.
No. We supply material and documentation. We do not provide dosing guidance, administration routes or frequencies, reconstitution media or volumes, protocols or cycles, and we do not refer enquirers elsewhere for them. Questions about batch paperwork, specifications and certificates are welcome.







